OUR VALUES
-
abhayam
Fearlessness
The confidence to boldly enter unforseen markets and transcend boundaries between conventional disciplines.
-
achapalam
Focus
We focus our energy on the science, technology, and enterprises that can create the greatest impact on our planet.
-
arjavam
Transparency of Character
Straightforwardness — Acting all times in tune with our personal mission, corporate mission and our broader global mission.
-
dhriti
Steadfastness
The ability to withstand daily undulations in hypergrowth environments and volatile markets and venture into the new markets with steady, unwavering determination against the winds of resistance.
-
tapas
Self-discipline
The relentless quest to infuse efficiency, precision, and excellence into everything we do.
-
satya
Truthfulness
We strive to be true to ourselves, at all times. We will never rest on our laurels, but continuously strive to grow further.
-
tyaga
Renunciation
We seek to create long term sustainable impact.
Videos
Nanobiosym XPRIZE Video
Search results
Gene-RADAR®-based Services
on our Gene-RADAR platform to help accelerate FDA approvals
READ MORE
Nanobiosym Selected As One Of The Top Growth Stage Ventures By The ‘Unreasonable’ Group
After a rigorous and highly competitive selection process involving hundreds of companies across the globe, Nanobiosym® has been selected as one of the world’s top 15 growth-stage ventures that will be backed by the Unreasonable Group as entrepreneurs who…
READ MORE
FDA Grants Nanobiosym Diagnostics Emergency Use Authorization for Gene-RADAR® Zika Virus Test
FDA Authorization for the Gene-RADAR® Zika Virus Test on the XPRIZE-Winning Gene-RADAR® Platform
READ MORE
Nanobiosym's Gene-RADAR® Unveiled as the ‘Next Frontier’ in Healthcare Technology at the Clinton Global Initiative Annual Meeting
Today at the Clinton Global Initiative (CGI) Annual Meeting’s “Looking to the Next Frontier” Plenary Session with Sir Richard Branson and Dr. Neil deGrasse Tyson, Dr. Anita Goel announced Nanobiosym’s commitment to deploy Gene-RADAR® in Africa to stop Ebo…
READ MORE
Silicon Valley must join the Ebola battle before it becomes a matter of survival
In this Washington Post article urging Silicon Valley tech firms to join the Ebola battle, contributor Vivek Wadhwa mentions Nanobiosym’s Gene-RADAR as “…one of the most promising technologies of all” in fighting global pandemics.
READ MORE
We Really Are Living in the (Medical) Future
As a featured innovator in Marketplace Morning Report’s “Big Ideas” series, Dr. Goel discusses Gene-RADAR® and the future of healthcare with host David Brancaccio.
READ MORE
How Today’s Technology is Rapidly Catching up to Star Trek
Similar advances in microfluidics and nanofluidics are enabling development of labs on thumbnail-sized chips. Nanobiosym, for example is developing a device, called Gene-RADAR, that can identify, within minutes, a range of illnesses, including AIDS, malar…
READ MORE
New Test Can Detect HIV without Running Water, Electricity or Trained Staff
The size of an iPad, the Gene-RADAR diagnostic test may someday offer a real-time analysis of not just HIV, but also tuberculosis, malaria, and other diseases.
READ MORE
Cambridge Company Creates iPad-Sized Tech to Diagnose Diseases in Real-Time
Nanobiosym founder Dr. Anita Goel discusses Gene-RADAR®, a device the size of an iPad that contains the power to diagnose diseases in real-time.
Cambridge Company Creates iPad-Sized Tech to Diagnose Diseases in Real-Time
READ MORE
Nanobiosym's Gene-RADAR® Diagnoses Diseases Faster
An iPad-size device that takes less than an hour to diagnose diseases with genetic footprints, including HIV, malaria, tuberculosis, and some types of cancer
Nanobiosym's Gene-RADAR® Diagnoses Diseases Faster
READ MORE
Rethinking Assumptions: Five Opportunities to Leapfrog in Global Development
Gene-RADAR® by Nanobiosym, a Cambridge, Massachusetts based biotech startup, allows for rapid, accurate, field-based molecular sequencing of HIV
Rethinking Assumptions: Five Opportunities to Leapfrog in Global Development
READ MORE
Mobile disease sensor wins first Nokia Sensing XCHALLENGE
Nanobiosym Gene-RADAR® was named the winner from a pool of 26 competing teams from seven countries, and will receive a $525,000 grand prize
Mobile disease sensor wins first Nokia Sensing XCHALLENGE
READ MORE
